Iwona Hus

1.9k total citations
96 papers, 1.2k citations indexed

About

Iwona Hus is a scholar working on Genetics, Immunology and Oncology. According to data from OpenAlex, Iwona Hus has authored 96 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Genetics, 44 papers in Immunology and 28 papers in Oncology. Recurrent topics in Iwona Hus's work include Chronic Lymphocytic Leukemia Research (49 papers), Lymphoma Diagnosis and Treatment (27 papers) and Immunodeficiency and Autoimmune Disorders (18 papers). Iwona Hus is often cited by papers focused on Chronic Lymphocytic Leukemia Research (49 papers), Lymphoma Diagnosis and Treatment (27 papers) and Immunodeficiency and Autoimmune Disorders (18 papers). Iwona Hus collaborates with scholars based in Poland, Germany and United States. Iwona Hus's co-authors include Jacek Roliński, Anna Dmoszyńska, Agnieszka Bojarska−Junak, Krzysztof Giannopoulos, Michael Schmitt, Jacek Tabarkiewicz, Jochen Greiner, Ewa Wąsik‐Szczepanek, Anita Schmitt and Tadeusz Robak and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Iwona Hus

85 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iwona Hus Poland 18 710 458 451 254 239 96 1.2k
Harry R. Koene Netherlands 14 652 0.9× 343 0.7× 241 0.5× 379 1.5× 186 0.8× 36 1.3k
Jörg Westermann Germany 21 611 0.9× 476 1.0× 193 0.4× 338 1.3× 103 0.4× 85 1.2k
John C. Riches United Kingdom 17 861 1.2× 1.1k 2.3× 648 1.4× 330 1.3× 405 1.7× 44 1.9k
W. Christopher Ehmann United States 18 600 0.8× 762 1.7× 238 0.5× 216 0.9× 318 1.3× 43 1.4k
Nathanael G. Bailey United States 22 527 0.7× 498 1.1× 384 0.9× 392 1.5× 711 3.0× 67 1.6k
Kerry L. Cox United Kingdom 15 510 0.7× 301 0.7× 310 0.7× 333 1.3× 236 1.0× 24 1.1k
Valérie Coiteux France 19 594 0.8× 630 1.4× 596 1.3× 233 0.9× 157 0.7× 53 1.8k
Sean H. Lim United Kingdom 13 552 0.8× 417 0.9× 386 0.9× 236 0.9× 385 1.6× 33 1.2k
Benoît Tessoulin France 18 219 0.3× 516 1.1× 244 0.5× 436 1.7× 306 1.3× 79 1.2k
Jean‐Jacques Sotto France 17 366 0.5× 410 0.9× 190 0.4× 406 1.6× 187 0.8× 42 1.1k

Countries citing papers authored by Iwona Hus

Since Specialization
Citations

This map shows the geographic impact of Iwona Hus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iwona Hus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iwona Hus more than expected).

Fields of papers citing papers by Iwona Hus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iwona Hus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iwona Hus. The network helps show where Iwona Hus may publish in the future.

Co-authorship network of co-authors of Iwona Hus

This figure shows the co-authorship network connecting the top 25 collaborators of Iwona Hus. A scholar is included among the top collaborators of Iwona Hus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iwona Hus. Iwona Hus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hus, Iwona, Krzysztof Giannopoulos, Krzysztof Jamroziak, et al.. (2025). Rekomendacje diagnostyczne i terapeutyczne dla przewlekłej białaczki limfocytowej w 2025 roku — Raport Grupy Roboczej PTHiT i PALG-CLL. SHILAP Revista de lepidopterología. 5(1-2). 20–47. 1 indexed citations
2.
Puła, Bartosz, Elżbieta Iskierka‐Jazdzewska, Krzysztof Jamroziak, et al.. (2024). Expert opinion on use of acalabrutinib for chronic lymphocytic leukemia treatment. Acta Haematologica Polonica. 55(3). 130–136. 2 indexed citations
3.
Hus, Iwona, et al.. (2023). COVID-19 in Adult Patients with Hematological Malignancies—Lessons Learned after Three Years of Pandemic. Biology. 12(4). 545–545. 6 indexed citations
4.
Drozd‐Sokołowska, Joanna, Ewa Paszkiewicz‐Kozik, Marta Morawska, et al.. (2023). Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia—a real-world analysis of the Polish Adult Leukemia Study Group. Annals of Hematology. 102(8). 2119–2126. 4 indexed citations
5.
Ścibior, Agnieszka, et al.. (2020). Evaluation of the level of selected iron-related proteins/receptors in the liver of rats during separate/combined vanadium and magnesium administration. Journal of Trace Elements in Medicine and Biology. 61. 126550–126550. 4 indexed citations
6.
Pawłowska, Małgorzata, Robert Flisiak, Lidia Gil, et al.. (2019). Prophylaxis of hepatitis B virus (HBV) infection reactivation – recommendations of the Working Group for prevention of HBV reactivation. Clinical and Experimental Hepatology. 5(3). 195–202. 20 indexed citations
7.
Rupa‐Matysek, Joanna, et al.. (2019). Unexplained anemia in the elderly – a real life analysis of 981 patients. Archives of Medical Science. 16(4). 834–841. 15 indexed citations
8.
Władysiuk, Magdalena, et al.. (2018). Treatment options in chronic lymphocytic leukemia (CLL) – a Polish perspective. 20–33. 3 indexed citations
9.
Bojarska−Junak, Agnieszka, et al.. (2013). CD1d expression is higher in chronic lymphocytic leukemia patients with unfavorable prognosis. Leukemia Research. 38(4). 435–442. 22 indexed citations
10.
Tomkiewicz, Anna, Edyta Pawlak, Olga Grzybowska‐Izydorczyk, et al.. (2013). Intronic SNP - rs9288953 Of Suppressor Molecule Btla Confers Susceptibility To B-Cell Chronic Lymphocytic Leukemia. Blood. 122(21). 5286–5286. 1 indexed citations
11.
Twardosz, Anna, Paulina Wdowiak, Agata Surdacka, et al.. (2011). CD3+/CD16+CD56+ cell numbers in peripheral blood are correlated with higher tumor burden in patients with diffuse large B-cell lymphoma. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Bojarska−Junak, Agnieszka, Iwona Hus, Agata Surdacka, et al.. (2011). Clinical immunology The role of TACI expression in chronic lymphocytic leukemia. Central European Journal of Immunology. 36(1). 46–50. 2 indexed citations
13.
Wdowiak, Paulina, et al.. (2011). Clinical immunology The estimation of B7 family molecule expression on dendritic cells generated from CLL patients. Central European Journal of Immunology. 36(1). 33–36. 1 indexed citations
14.
Hus, Iwona, et al.. (2011). Clinical immunology iNKT cell percentage is decreased in patients with chronic lymphocytic leukemia and correlates inversely with the clinical stage and negative prognostic factors. Central European Journal of Immunology. 36(2). 79–84. 2 indexed citations
15.
Hus, Iwona, Elżbieta Starosławska, Agnieszka Bojarska−Junak, et al.. (2011). CD3<sup>+</sup>/CD16<sup>+</sup>CD56<sup>+</sup> cell numbers in peripheral blood are correlated with higher tumor burden in patients with diffuse large B-cell lymphoma. Folia Histochemica et Cytobiologica. 49(1). 183–187. 13 indexed citations
16.
17.
18.
Tabarkiewicz, Jacek, Sebastian Radej, Iwona Hus, et al.. (2008). Dendritic cells based immunotherapy of patient with chondrosarcoma--case report.. Folia Histochemica et Cytobiologica. 46(2). 165–70. 4 indexed citations
19.
Hus, Iwona, Monika Podhorecka, Agnieszka Bojarska−Junak, et al.. (2006). The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia. Annals of Oncology. 17(4). 683–690. 76 indexed citations
20.
Hus, Iwona, Anna Dmoszyńska, Marek Hus, et al.. (2004). An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma. British Journal of Cancer. 91(11). 1873–1879. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harry R. Koene Breakdown of academic impact, for papers by Jörg Westermann Breakdown of academic impact, for papers by John C. Riches Breakdown of academic impact, for papers by W. Christopher Ehmann Breakdown of academic impact, for papers by Nathanael G. Bailey Breakdown of academic impact, for papers by Kerry L. Cox Breakdown of academic impact, for papers by Valérie Coiteux Breakdown of academic impact, for papers by Sean H. Lim Breakdown of academic impact, for papers by Benoît Tessoulin Breakdown of academic impact, for papers by Jean‐Jacques Sotto
Rankless by CCL
2026